Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance

This publication has 41 references indexed in Scilit:

• Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
  Journal of Parasitology, 1997
• Prevalence of Toxoplasma gondii Antibodies in U.S. Military Recruits in 1989: Comparison with Data Published in 1965
  Clinical Infectious Diseases, 1996
• Toxoplasmic Encephalitis in AIDS
  Clinical Infectious Diseases, 1992
• Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)
  Biochemical Pharmacology, 1992
• Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii
  Antimicrobial Agents and Chemotherapy, 1991
• Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis
  Antimicrobial Agents and Chemotherapy, 1990
• Toxoplasmosis: the Time Has Come
  New England Journal of Medicine, 1988
• Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro
  Molecular and Biochemical Parasitology, 1985
• Conversion of dihydroorotate to orotate in parasitic protozoa
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1979
• Specific Labeling of Intracellular Toxoplasma gondii with Uracil*
  The Journal of Protozoology, 1977